TNF and inflammatory bowel disease: However, current drug therapies for IBD are far from optimal3: the efficacy of aminosalicylates is modest; steroids are effective but cause severe complications; and biologic therapies such as anti-tumor necrosis factor (TNF)-α antibody are associated with increased opportunistic infections in some patients4.